-
Mashup Score: 0Chronic Pain - 2 year(s) ago
Chronic pain is more common than most people can imagine, affecting people of all ages and stages in life.
Source: www.bostonscientific.comCategories: Latest Headlines, Pain ManagementTweet
-
Mashup Score: 0
Title: Spinal Cord Stimulation Trialing: Is Trialing Predictive of Short, Intermediate, and Long-term Pain Outcomes? Introduction: Spinal cord stimulation (SCS) is a proven, effective treatment for chronic neuropathic back and limb pain. Recently, emphasis has been placed on methods to improve long-term efficacy and reduce explant rates. •SCS trial is used as a prognostic tool. • Successful…
Source: epostersonline.comCategories: Latest Headlines, NeurologyTweet-
This study questions the prognostic capabilities of patient-reported SCS trial pain outcomes in predicting #SCS implant outcomes At best, they provide 40% of needed information 🔥 @DProvenzanoMD #ASRAfall22 #neuromodulation @ASRA_Society @NANS_ION 👉🏼https://t.co/SaknrM7KYz https://t.co/Y0AnNCgMk0
-
-
Mashup Score: 0Chronic Pain Real Patient Stories - 2 year(s) ago
Hear stories from people who have been in your shoes, that suffer chronic pain and use a SCS or RFA system to help manage their pain.
Source: www.bostonscientific.comCategories: Latest Headlines, Pain ManagementTweet-
Hear stories from people who have been in your shoes, have chronic pain, and use a Spinal Cord Stimulator (#SCS) system to help manage their pain: https://t.co/GoNiBT3CKW #SpinalCordStimulation #BSCEMEA
-
-
Mashup Score: 2Spinal Cord Stimulation (SCS) Clinical Data - 2 year(s) ago
Boston Scientific’s SCS therapy is backed by years of science and extensive clinical evidence. This includes multiple Level I RCTs and Real-world studies that support the design of the Alpha WaveWriter SCS system. LEVEL I COMBO RCT …
Source: www.bostonscientific.comCategories: Latest Headlines, Pain ManagementTweet-
#SpinalCordStimulation therapy by Boston Scientific is backed by years of science and extensive clinical evidence, showing the safety, efficacy & longevity of the WaveWriter Alpha #SCS system. Read more about the clinical data on SCS: https://t.co/hpXMpnD2qZ #ChronicPain #BSCEMEA https://t.co/ynic8Q4q3p
-
-
Mashup Score: 1Effect of Spinal Cord Burst Stimulation vs Placebo Stimulation on Disability in Patients After Lumbar Spine Surgery - 2 year(s) ago
This placebo-controlled, crossover randomized clinical trial compares the effects of spinal cord burst stimulation vs placebo stimulation in patients with chronic radiculopathy after surgery for degenerative lumbar spine disorders.
Source: jamanetwork.comCategories: Latest Headlines, NeurologyTweet-
🆕 @JAMANetworkOpen Spinal cord burst stimulation #SCS compared w placebo stimulation -> no significant difference in self-reported back pain related disability -50 patients -placebo-controlled, crossover, randomized trial -University hospital 🇳🇴 https://t.co/KpePvXwIBx
-
-
Mashup Score: 0Pain Medicine Meeting - 2 year(s) ago
Save!Early-bird registration deadline: October 6, 2022 Join us Thursday, November 17, through Saturday, November 19, 2022, to learn, network, and be inspired! This three-day scientific and educational event allows you to tailor your educational experience and select content based on your individual needs. Content will deliver information and skills that you can put to immediate use in…
Categories: Latest Headlines, NeurologyTweet-
#ASRAfall22 💥Late-Breaking Session💥 -🆕 #SCS trialing guidelines -Maintaining Patient Access -Coverage Expansion -Economic Viability 📣We need YOUR feedback on new guidelines @ASRA_Society @ESRA_Society @NANS_ION @harshamd5 @DProvenzanoMD, Eldabe 👉🏼https://t.co/qGZZ7k6Mxr https://t.co/E8CRJZyjmW
-
-
Mashup Score: 1Prospects of neuromodulation for chronic pain - 2 year(s) ago
For over half a century neuromodulation has been successfully used for treatment of chronic pain syndromes. There is a growing number of new modes or …
Source: www.sciencedirect.comCategories: Healthcare Professionals, Latest HeadlinesTweet-
Prospects of #neuromodulation for #chronicpain https://t.co/l2cISODiD8 #SCS #neuropathicpain #opsins #Optogenetics #spinalcord
-
-
Mashup Score: 1Durability of Clinical and Quality-of-Life Outcomes of Closed-Loop Spinal Cord Stimulation for Chronic Back and Leg Pain - 2 year(s) ago
This secondary analysis of a randomized clinical trial determines whether evoked compound action potentials–controlled, closed-loop spinal cord stimulator is associated with better outcomes compared with fixed-output, open-loop spinal cord stimulator at 24 months following implant.
Source: jamanetwork.comCategories: Latest Headlines, NeurologyTweet-
#RCTevidence found that #ECAP-controlled closed-loop spinal cord stimulation (SCS) provided #chronicpain reduction superior to open-loop #SCS maintained through 2 yrs. https://t.co/luFzIt4czI
-
-
Mashup Score: 0Medtronic, Nevro boosted by expansion of Medicare coverage for diabetic pain devices - 2 year(s) ago
Nevro, which was first to market but quickly joined by Medtronic, said around 43% of U.S. patients with painful diabetic neuropathy are now covered, up from 25% at the end of last year.
Source: MedTech DiveCategories: Healthcare Professionals, Latest HeadlinesTweet-
.@Medtronic @Nevro_HFX boosted by expansion of #Medicare coverage for diabetic #pain devices | #diabetes #neuropathy #SCS spinal cord stimulation https://t.co/4HJMRmvuBI
-
-
Mashup Score: 0Medtronic gets earlier-than-expected FDA approval for pain device, raising concerns among Nevro investors - 2 year(s) ago
The premarket approval, which Medtronic wasn’t expected to seek until 2023, positions it to compete with Nevro for a market it values at $1.8 billion.
Source: MedTech DiveCategories: Healthcare Professionals, Latest HeadlinesTweet-
.@Medtronic gets earlier-than-expected #FDA approval for #pain device, raising concerns among Nevro investors - spinal cord stimulation #SCS, #diabetes peripheral #neuropathy https://t.co/fPOycfhOEK
-
Did you know❔ The WaveWriter real-world data for #SpinalCordStimulation (SCS) therapy by @bostonsci demonstrated significant and sustained pain relief in the real world out to two years. Learn more about #PainManagement with #SCS: https://t.co/8WOhENBezT #ChronicPain #BSCEMEA https://t.co/Q306cegAiC